Soleno Therapeutics (SLNO) announced with deep sadness the passing of former Chairman of the Board of Directors, Ernest Mario, Ph.D, at the age of 86 years. Dr. Mario served as the Soleno’s Chairman from 2007 through August 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- PepsiCo reports mixed Q3, Roblox slips after short report: Morning Buzz
- Soleno Therapeutics update on DCCR ‘a positive surprise,’ says Stifel
- Soleno says FDA sees no need for advisory committee meeting for DCCR NDA
- Soleno Therapeutics price target raised to $74 from $59 at Stifel
- Soleno Therapeutics initiated with a Buy at H.C. Wainwright